CJ
IDXX icon

Caitlin John’s Idexx Laboratories IDXX Stock Holding History

Caitlin John’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63K Hold
5
– – ﹤0.01% 750
2026
Q1 		$2.81K Hold
5
– – ﹤0.01% 678
2025
Q4 		$3.38K Hold
5
– – ﹤0.01% 675
2025
Q3 		$3.19K Buy
+5
New +$3.04K ﹤0.01% 640
2025
Q1 		– Sell
-25
Closed -$10.3K – 425
2024
Q4 		$10.3K Hold
25
– – 0.01% 477
2024
Q3 		$10.7K Hold
25
– – 0.01% 480
2024
Q2 		$12.2K Hold
25
– – 0.01% 431
2024
Q1 		$13.5K Hold
25
– – 0.01% 411
2023
Q4 		$13.9K Buy
+25
New +$11.7K 0.01% 386

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Caitlin John's IDXX Position: Q2 2026 in Review

Caitlin John held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 5 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

Caitlin John first reported a position in IDXX in Q4 2023 and has held it in 9 quarters since. The position peaked at $13.9K in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Caitlin John held 5 shares of Idexx Laboratories worth $2.63K as of Q2 2026.
  • Caitlin John left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #750 holding.
  • Caitlin John first reported a position in Idexx Laboratories in Q4 2023 and has held it in 9 quarters since.
  • Caitlin John's Idexx Laboratories position peaked at $13.9K in Q4 2023.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.